Sousa Alioscka A, Hassan Sergio A, Knittel Luiza L, Balbo Andrea, Aronova Maria A, Brown Patrick H, Schuck Peter, Leapman Richard D
Department of Biochemistry, Federal University of São Paulo, São Paulo, SP, Brazil.
Center for Molecular Modeling, DCB/CIT, National Institutes of Health, Bethesda, MD, USA.
Nanoscale. 2016 Mar 28;8(12):6577-88. doi: 10.1039/c5nr07642k.
Recent in vivo studies have established ultrasmall (<3 nm) gold nanoparticles coated with glutathione (AuGSH) as a promising platform for applications in nanomedicine. However, systematic in vitro investigations to gain a more fundamental understanding of the particles' biointeractions are still lacking. Herein we examined the behavior of ultrasmall AuGSH in vitro, focusing on their ability to resist aggregation and adsorption from serum proteins. Despite having net negative charge, AuGSH particles were colloidally stable in biological media and able to resist binding from serum proteins, in agreement with the favorable bioresponses reported for AuGSH in vivo. However, our results revealed disparate behaviors depending on nanoparticle size: particles between 2 and 3 nm in core diameter were found to readily aggregate in biological media, whereas those strictly under 2 nm were exceptionally stable. Molecular dynamics simulations provided microscopic insight into interparticle interactions leading to aggregation and their sensitivity to the solution composition and particle size. These results have important implications, in that seemingly small variations in size can impact the biointeractions of ultrasmall AuGSH, and potentially of other ultrasmall nanoparticles as well.
最近的体内研究已证实,包覆谷胱甘肽的超小(<3纳米)金纳米颗粒(AuGSH)是纳米医学应用中一个很有前景的平台。然而,目前仍缺乏系统的体外研究,以更深入地了解这些颗粒的生物相互作用。在此,我们研究了超小AuGSH在体外的行为,重点关注其抵抗血清蛋白聚集和吸附的能力。尽管AuGSH颗粒带净负电荷,但它们在生物介质中具有胶体稳定性,并且能够抵抗血清蛋白的结合,这与体内报道的AuGSH良好生物反应一致。然而,我们的结果显示,根据纳米颗粒大小不同,行为存在差异:发现核心直径在2至3纳米之间的颗粒在生物介质中容易聚集,而严格小于2纳米的颗粒则异常稳定。分子动力学模拟提供了对导致聚集的颗粒间相互作用及其对溶液组成和颗粒大小敏感性的微观见解。这些结果具有重要意义,因为看似微小的尺寸变化可能会影响超小AuGSH的生物相互作用,也可能影响其他超小纳米颗粒的生物相互作用。